Table 3.

Summary of first and second cohort results based on family history of AUD

Outcome Measure	Original Cohort (Dose × Time × FH)				Second Cohort (Dose × Time × FH)				Between Cohort Comparison (Dose × Time × FH × Cohort)
	Na (FH+)	F	P	f b	N (FH+)	F	P	f	F	P
BAES
Stimulation	81 (43)	0.4	0.84	0.07	83 (47)	1.0	0.41	0.11	0.5	0.77
Sedation	81 (43)	0.3	0.89	0.06	83 (47)	0.3	0.85	0.07	0.1	0.99
DEQ
Like	81 (43)	0.3	0.80	0.07	83 (47)	0.2	0.89	0.05	0.5
Want More	81 (43)	0.2	0.88	0.05	83 (47)	0.1	0.96	0.03	0.1	0.97
Salivary Cortisol	81 (43)	3.5	0.008	0.21	82 (46)	1.2	0.33	0.12	0.6	0.70
Smooth Pursuit
Gain	75 (40)	4.5	0.01	0.25	83 (47)	1.7	0.19	0.14	0.3	0.75
Pro-saccade
Latency	77 (42)	0.5	0.62	0.08	82 (47)	0.8	0.48	0.10	1.2	0.30
Velocity	77 (42)	1.9	0.16	0.16	82 (47)	0.1	0.90	0.04	0.7	0.51
Accuracy	77 (42)	2.8	0.06	0.20	82 (47)	0.3	0.78	0.06	1.9	0.15
Anti-saccade
Latency	77 (42)	0.6	0.57	0.09	79 (46)	0	0.96	0.02	0.2	0.85
Velocity	77 (42)	1.1	0.33	0.12	79 (46)	1.3	0.28	0.13	0.8	0.45
Accuracy	77 (42)	3.7	0.03	0.22	79 (46)	1.8	0.18	0.15	1.1	0.32
DSST	81 (43)	0.3	0.85	0.07	83 (47)	1.4	0.22	0.13	0.9	0.50
Pegboarda	81 (43)	0.4	0.79	0.07	83 (47)	0.9	0.48	0.11	0.3	0.91

^aNumber of participants identified as either FH+ or FH−.

^bEffect size as measured by Cohen’s f